Brightway Pharmaceuticals Private Limited
About Brightway Pharmaceuticals Private Limited
Data last updated:
Brightway Pharmaceuticals Private Limited is a private limited company based in Solapur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2016PTC166851. Its GSTIN is 27AAGCB9248N1Z0 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Akbar Abdul Gani Loni and Sirajoddin Abdulgafoor Shaikh.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Shop No. 7 Square One Com 131 Sidheshwar Peth Gr Fl Solapur 413003, Maharashtra, India – 413003.
As per the financials filed for FY 2022, the company reported a revenue of ₹9.49 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹60,951 (net margin -6.4%) and EBITDA of -₹60,951 (EBITDA margin -6.4%). Revenue has grown at a compounded annual rate (CAGR) of 26% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Brightway Pharmaceuticals Private Limited's registered office is in Solapur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 7 Square One Com 131 Sidheshwar Peth Gr Fl Solapur 413003, Maharashtra, India – 413003
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Brightway Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Brightway Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Brightway Pharmaceuticals Private Limited, buy the company report.
Financials of Brightway Pharmaceuticals Private Limited
FY 2022 filings availableBrightway Pharmaceuticals Private Limited reported revenue of ₹9.49 Lakh (up 524% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 524% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹9.49 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹60,951 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹60,951 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.4% | ||||
| Net Profit Margin | -6.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brightway Pharmaceuticals Private Limited, buy the company report.
Board of directors of Brightway Pharmaceuticals Private Limited
Brightway Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akbar Abdul Gani Loni | Director | 19 Oct 2016 | 10 Years 0 Months | Current |
| Sirajoddin Abdulgafoor Shaikh | Director | 07 Aug 2017 | 9 Years 3 Months | Current |
Auditor
Brightway Pharmaceuticals Private Limited is audited by DIPAK M VYAVAHARE & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DIPAK M VYAVAHARE & CO | FY 2021 | 134311W |
Shareholding
The shareholding of Brightway Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Brightway Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Brightway Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Brightway Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Brightway Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCB9248N1Z0 | Maharashtra | Active | 04 Sep 2017 |
To see the full GST registrations and return filing status of Brightway Pharmaceuticals Private Limited, buy the company report.
Recent activity
Brightway Pharmaceuticals Private Limited has 8 board changes on record since 2016: 5 appointments and 3 cessations. The latest: Mahiboob Siddakaji Hannure ceased to be Additional Director on 01 Dec 2021.
Frequently asked questions
Brightway Pharmaceuticals is an active private limited company based in Solapur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 October 2016 (10+ years old) and is registered under CIN U74999PN2016PTC166851.
Brightway Pharmaceuticals has 2 current directors:
- Akbar Abdul Gani Loni - Director
- Sirajoddin Abdulgafoor Shaikh - Director
The latest financial statements of Brightway Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Brightway Pharmaceuticals is 27AAGCB9248N1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Brightway Pharmaceuticals is U74999PN2016PTC166851. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brightway Pharmaceuticals was incorporated on 19 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
Mahiboob Siddakaji Hannure ceased to be Additional Director on 01 Dec 2021. Mahiboob Siddakaji Hannure was appointed as Additional Director on 31 Dec 2019. Abduljalil Babulal Loni ceased to be Director on 07 Aug 2017. Brightway Pharmaceuticals has 8 board changes on record in total.
The registered office of Brightway Pharmaceuticals is at Shop No. 7 Square One Com 131 Sidheshwar Peth Gr Fl Solapur 413003, Maharashtra, India – 413003.
Brightway Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Brightway Pharmaceuticals is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
